The Leser-Trélat sign is an uncommon dermatological manifestation characterized by the sudden and rapid onset of multiple seborrheic keratoses, variably distributed across the body. Its clinical significance lies in its association with underlying neoplasms, primarily solid tumors such as gastric, colon, and breast adenocarcinomas. Less frequently, it has been linked to hematological and lymphoid malignancies, reinforcing its role as a paraneoplastic syndrome. These lesions may appear as an isolated finding or alongside other systemic signs, emphasizing the importance of a comprehensive diagnostic approach to identify potential associated neoplasms. We present the case of a 72-year-old male patient who sought medical attention for constitutional symptoms, fever, nocturnal chills, and abdominal distension. Sudden-onset brown seborrheic and keratotic lesions were noted on his chest, back, abdomen, axillary, and cervical regions. Following evaluation, the patient was diagnosed with chronic myeloid leukemia. Given his advanced age and clinical condition, a palliative approach was chosen due to the high risk of complications with chemotherapy, and the patient was subsequently discharged. This case highlights the importance of recognizing the Leser-Trélat sign as a critical clinical marker for occult neoplasms. Its identification should prompt a thorough evaluation, particularly in patients with systemic symptoms, as it may provide the key to early diagnosis and optimized therapeutic planning.
Pipkin, C.A. and Lio, P.A. (2008) Cutaneous Manifestations of Internal Malignancies: An Overview. DermatologicClinics, 26, 1-15. https://doi.org/10.1016/j.det.2007.08.002
[3]
Tibaduiza Mogollon, Y.A., Miranda Diaz, A.J. and Navas Torrejano, D.S. (2019) Signo de Leser-Trélat, signo paraneoplásico en cáncer de mama metastásico: Presen-tación de caso. RevistaMed, 26, 60-64. https://doi.org/10.18359/rmed.3554
[4]
Schwartz, R.A. (1996) Sign of Leser-Trelat. JournaloftheAmericanAcademyofDermatology, 35, 88-95. https://doi.org/10.1016/s0190-9622(96)90502-2
[5]
Safa, G. and Darrieux, L. (2011) Leser-Trélat Sign without Internal Malignancy. CaseReportsinOncology, 4, 175-177. https://doi.org/10.1159/000327363
[6]
Sánchez López, J.D., Gómez García, E. and Rodríguez Ruiz, J. (2021) Signo de Leser-Trelat, un predictor útil de neoplasias en atención primaria? MedicinadeFamiliaSemergen, 47, e45-e46. https://doi.org/10.1016/j.semerg.2021.02.002
[7]
Report, C. (2022) Trélat Syndrome Secondary to Non-Cell Lung Carcinoma. https://doi.org/10.1002/ccr3.6069
[8]
Irvine, U.C. (2023) Images in Emergency Medicine Leser-Trélat Sign as a Marker for Underlying Pancreatic Cancer. https://doi.org/10.5811/cpcem.1248
[9]
André, R., Laffitte, E., Abosaleh, M., Cortès, B., Toutous-Trellu, L. and Kaya, G. (2018) Sign of Leser-Trélat and Cutaneous T-Cell Lymphoma: A Rare Association. Dermatopathology, 5, 69-73. https://doi.org/10.1159/000488982
[10]
Martínez-Morán, C., Sanz-Muñoz, C. and Miranda-Romero, A. (2007) Signo de Leser-Trélat asociado a síndrome de Sézary y a carcinoma de células transicionales de vejiga. ActasDermo-Sifiliográficas, 98, 214-215. https://doi.org/10.1016/s0001-7310(07)70052-2
[11]
Mantilla, A.F., Díaz-Martínez, L.A., Ballesteros, Z.J., Chávez, M.J., Mesa, L.L. and Solier Insuasty, J. (2014) El signo de Leser-Trélat un predictor de neoplasias útil en clínica? ActaMédicaColombiana, 39, 272-278. https://doi.org/10.36104/amc.2014.320
[12]
Mathez, A.L.G., Moroto, D., Dib, S.A. and de Sa, J.R. (2016) Seborrheic Keratoses and Severe Hypoinsulinemic Hypoglycemia Associated with Insulin Grow Factor 2 Secretion by a Malignant Solitary Fibrous Tumor. Diabetology&MetabolicSyndrome, 8, Article No. 33. https://doi.org/10.1186/s13098-016-0148-2
[13]
Pelosof, L.C. and Gerber, D.E. (2010) Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. MayoClinicProceedings, 85, 838-854. https://doi.org/10.4065/mcp.2010.0099
[14]
Suening, B.S. and Neidenbach, P.J. (2023) The Pseudo-Sign of Leser-Trélat: A Rare Presentation. Cureus, 15, e35155. https://doi.org/10.7759/cureus.35155
[15]
Flores Palomar, F.J., Boyer Duck, E., Vargas Chandomid, E., Escobar Arriaga, E., Montes de Oca Orellana, C.R., Alfeirán Ruiz, A., et al. (2019) Signo de Leser-Trélat, como manifestación inicial en adenocarcinoma gástrico oculto. Acta Médica Grupo Angeles, 17, 274-277. http://surl.li/euztkn
[16]
Shah, N.P., Bhatia, R., Altman, J.K., Amaya, M., Begna, K.H., Berman, E., et al. (2024) Chronic Myeloid Leukemia, Version 2.2024. Journal of the National Comprehensive Cancer Network, 22, 43-69.
[17]
Jabbour, E. and Kantarjian, H. (2020) Chronic Myeloid Leukemia: 2020 Update on Diagnosis, Therapy and Monitoring. AmericanJournalofHematology, 95, 691-709. https://doi.org/10.1002/ajh.25792
[18]
Fink, A., Filz, D., Krajnik, G., Jurecka, W., Ludwig, H. and Steiner, A. (2009) Seborrhoeic Keratoses in Patients with Internal Malignancies: A Case-Control Study with Prospective Accrual of Patients. JournaloftheEuropeanAcademyofDermatologyandVenereology, 23, 1316-1319. https://doi.org/10.1111/j.1468-3083.2009.03163.x
[19]
Lindelöf, B., Sigurgeirsson, B. and Melander, S. (1992) Seborrheic Keratoses and Cancer. JournaloftheAmericanAcademyofDermatology, 26, 947-950. https://doi.org/10.1016/0190-9622(92)70139-7